Ignite Creation Date:
2024-05-06 @ 6:52 PM
Last Modification Date:
2024-10-26 @ 2:56 PM
Study NCT ID:
NCT05817058
Status:
RECRUITING
Last Update Posted:
2024-07-03
First Post:
2023-03-22
Brief Title:
First-in-Human Dose Escalation Study of AFM28 in Patients With RelapsedRefractory Acute Myeloid Leukemia
Sponsor:
Affimed GmbH
Organization:
Affimed GmbH
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Acute Myeloid Leukemia |
Keywords: